

Cover Story
By Conor Hale
NCI will implement President Barack Obama's directive to ramp up the initiative in precision medicine, even if Congress doesn't appropriate specific funds for this purpose, Institute Director Harold Varmus told members of the National Cancer Advisory Board Feb. 12.
By Matthew Bin Han Ong
In Brief


Drugs & Targets
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community











